drugset / Trial / NCT02691676

Perioperative Fluid Therapy With Balanced Crystalloids

NCT02691676

Phase 3 Completed 112 enrolled University Hospital Olomouc
RandomizedParallel-groupOpen-labelTreatment

Summary

Introduction: The strategy of perioperative fluid therapy has an important impact not only on the circulating volume and perfusion of organs and tissues but also on the patient's internal environment. The study aimed at comparing the effects of perioperatively administered balanced crystalloid infusion solutions containing different amounts of metabolizable anions on homeostasis. Methods: In the prospective randomized study, patients were assigned to Plasmalyte (PL) and Ringerfundin (RF) Groups after their postoperative transfer to an intensive care unit (ICU). The infusion solutions were parenterally administered at 1000 mL/6 hours. Arterialized capillary blood was sampled at the time of transfer to the ICU (Time 0), and again at 2 hours and 6 hours from Time 0. The collected blood was tested for blood gas parameters using the Astrup method.

Timeline

Start
2014-01
Primary completion
2014-12
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Plasmalyte Other / unclassified 1000 ml Other
Comparator Ringerfundin Unknown 1000 ml Other